Table 2.
Emesis-free and nausea-free rates during individual days, the delayed (24–120 h) and overall phases (0–120 h) and complete control during the acute (0–24 h), delayed and overall phases
| Population (N = 86) | |
|---|---|
| N (%) | |
| Emesis freea | |
| Day 1 | 79 (91.9) |
| Day 2 | 79 (91.9) |
| Day 3 | 83 (96.5) |
| Day 4 | 86 (100) |
| Day 5 | 84 (97.7) |
| Delayed phase | 77 (89.5) |
| Overall study period | 76 (88.4) |
| Nausea freeb | |
| Day 1 | 73 (84.9) |
| Day 2 | 70 (81.4) |
| Day 3 | 77 (89.5) |
| Day 4 | 82 (95.3) |
| Day 5 | 82 (95.3) |
| Delayed phase | 65 (75.6) |
| Overall study period | 64 (74.4) |
| Complete controlc | |
| Acute phase | 77 (89.5) |
| Delayed phase | 73 (84.9) |
| Overall study period | 71 (82.6) |
aNo episodes of vomiting
bNo episodes of nausea of any grading
cNo vomiting episodes, no use of rescue medication, and no more than mild nausea